Android app Apple app link

Encouraging Early Data From Next-Gen Study Puts Bristol Myers' CAR T Therapy In The Spotlight For Autoimmune Diseases

By Yahoo! Finance   |   1 month ago
Encouraging Early Data From Next-Gen Study Puts Bristol Myers' CAR T Therapy In The Spotlight For Autoimmune Diseases

Bristol Myers Squibb shared promising data on CC-97540, a new CAR T Cell Therapy for autoimmune diseases, at ACR 2024. Manufactured using NEX-TTM process, it showed positive safety and efficacy results, demonstrating potential as a key growth driver for the company.

Read More

Did you find this insightful?

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.